Nov 16, 2022 / 08:20PM GMT
Timothy Minton Anderson - Wolfe Research, LLC - MD of Equity Research
Okay. Great. Well, thanks for joining us. I'm Tim Anderson, I'm the large cap biopharma analyst at Wolfe. And we're pleased to have with us Bristol-Myers Squibb for a fireside chat here. Chris Boerner, who's EVP and Chief Commercialization Officer at the company, joined Bristol in 2015, has held leadership positions in both the U.S. and ex-U.S. markets. And prior to Bristol, he was in various commercial roles at Seagen and Genentech and other places as well. So Chris, thanks for joining us.
Christopher S. Boerner - Bristol-Myers Squibb Company - Executive VP & Chief Commercialization Officer
My pleasure. Thanks for the invitation.
Questions and Answers:
Timothy Minton Anderson - Wolfe Research, LLC - MD of Equity ResearchI thought we'd start with maybe just some kind of 2023 outlook type of questions. So maybe you can just frame out what you see as pushes and pulls as we close out 2022.
Christopher S. Boerner -
Trustpilot
